CareRx Corporation
CareRx Corporation (CRRX.TO) Revenue
Annual & quarterly revenue history · segment & region breakdown
CRRX.TO · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsCareRx Corporation trailing twelve-month (TTM) revenue is $0.37B, an increase of 0.96% year-over-year from $0.37B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.37B | +$0.00B | +0.96% |
| 2024-12-31 | $0.37B | -$0.00B | -1.09% |
| 2023-12-31 | $0.37B | -$0.01B | -2.88% |
| 2022-12-31 | $0.38B | +$0.12B | +45.35% |
| 2021-12-31 | $0.26B | +$0.10B | +61.92% |
| 2020-12-31 | $0.16B | +$0.04B | +30.15% |
| 2019-12-31 | $0.12B | +$0.00B | +0.71% |
| 2018-12-31 | $0.12B | -$0.05B | -26.77% |
| 2017-12-31 | $0.17B | +$0.00B | +0.96% |
| 2016-12-31 | $0.17B | +$0.00B | +3.04% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income CareRx Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
CareRx Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CAD.
Data sourced from CareRx Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CRRX.TO revenue · 4 questionsCRRX.TO's trailing twelve-month (TTM) revenue is $0.37B. That is an increase of 0.96% year-over-year from $0.37B in FY2025.
▸ Source: FMP · CareRx Corporation SEC filings · GAAP · CareRx Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026